lactic acid has been researched along with cucurbitacin i in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamdy, S; Lavasanifar, A; Ma, Z; Molavi, O; Samuel, J | 1 |
| Hamdy, S; Hung, RW; Lai, R; Lavasanifar, A; Mahmud, A; Molavi, O; Samuel, J | 1 |
2 other study(ies) available for lactic acid and cucurbitacin i
| Article | Year |
|---|---|
Immunomodulatory and anticancer effects of intra-tumoral co-delivery of synthetic lipid A adjuvant and STAT3 inhibitor, JSI-124.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Combined Chemotherapy Protocols; Dendritic Cells; Drug Delivery Systems; Glycolates; Immune Tolerance; Injections, Intralesional; Lactic Acid; Lipid A; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; STAT3 Transcription Factor; T-Lymphocytes, Regulatory; Triterpenes | 2009 |
Development of a poly(d,l-lactic-co-glycolic acid) nanoparticle formulation of STAT3 inhibitor JSI-124: implication for cancer immunotherapy.
Topics: Animals; Cell Line, Tumor; Cells, Cultured; Dendritic Cells; Flow Cytometry; Immunotherapy; Lactic Acid; Lymphocyte Culture Test, Mixed; Melanoma, Experimental; Mice; Models, Biological; Nanoparticles; Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; STAT3 Transcription Factor; Triterpenes | 2010 |